Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Evonik-Health-Care"

4 News Found

Evonik launches Eudracap preclinic functional oral capsule for preclinical trials
News | October 19, 2023

Evonik launches Eudracap preclinic functional oral capsule for preclinical trials

Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology

Evonik launches next-generation peptide for biopharma applications
News | June 02, 2023

Evonik launches next-generation peptide for biopharma applications

One thousand times more soluble than L-cystine at neutral pH

Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality
News | July 15, 2022

Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality

Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals

Evonik expands production of plant-derived cholesterol in Germany
News | March 06, 2022

Evonik expands production of plant-derived cholesterol in Germany

The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol

Latest Stories

Caplin Point gets Colombia approval for Softgel Capsules

Alembic Pharmaceuticals receives EIR from USFDA for oncology formulation facility

Lupin receives USFDA approval for travoprost ophthalmic solution

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
Vinod Paremal President & MD, Evonik, India Region

Packaging